Clonal Hematopoiesis Of Indeterminate Potential (CHIP)-A Pivotal Contributor Of Aging And Related Disorders
As we age, our bodies undergo many changes, and sometimes these changes can occur at a cellular level, even in our blood. A condition known as CHIP, or clonal hematopoiesis of indeterminate potential, describes a situation where a small number of our blood stem cells acquire specific genetic changes. These altered blood stem cells then begin to multiply more efficiently than their normal counterparts, leading to an increased proportion of these mutated cells in our blood. While many people with CHIP may not experience immediate symptoms, this cellular change is increasingly recognized as a significant factor contributing to the development of various age-related health problems. Notably, individuals with CHIP have a higher risk of developing serious conditions such as heart disease, stroke, and certain neurological disorders. This increased risk is often linked to the way these mutated blood cells can promote inflammation throughout the body. Understanding CHIP is crucial because it opens new avenues for research into how we can better manage and potentially prevent these common age-related diseases.
Source: link to paper